- About us
- About Vaccines
- Media centre
- Become a member
- VE Day 2013
How long for a vaccine to reach European Population? 6,4 years is the median time lag between marketing authorisation and effective population access
Vaccines Europe acts as the cohesive voice of the Europe-based vaccine industry sector and is a trusted partner for public authorities. Find out more about our association and contribution to Europe.
With 47% growth in R&D investment over the past eight years and over 70% of current R&D projects based on new antigens and new combinations, Vaccines Europe members highly contribute to innovation.
The vaccine industry is actively engaged in research & development of new vaccines that target diseases difficult to treat such as HIV/AIDS, cancer, Alzheimer and malaria among others, in view of improving public health.
As the EU-wide recognised vaccine industry stakeholder, Vaccines Europe represents major innovative research-based vaccine companies operating in Europe and is currently expanding to SMEs.
Find out more about our services, the opportunites we offer and how to become a member.
Vaccines Europe is pleased to announce the launch of the VaccinesToday Communication Challenge 2014, a competition aimed to engage university students from all over the EU to develop a creative video concept on how best to communicate on the importance of vaccination.
Europe is experiencing major outbreaks of vaccine-preventable infectious diseases in several countries, challenging WHO and EU targets for elimination. Diseases once thought nearly eradicated are making their re-appearance in close-by regions, and there are trends of decline in willingness to vaccinate on the part of both general public and healthcare professionals. Read more…
Vaccines Europe is pleased to announce the integration of its first vaccine SME members in the association; Vaxeal and ImmBio. These two companies are research biotechs investing in the development of innovative therapeutic and prophylactic vaccines targeting unmet medical needs.
Vaccines Europe is the voice of the vaccine industry in Europe and aims to create a supportive environment for innovative vaccine delivery and improved vaccine protection. Integrating SMEs in the Vaccines Europe membership will enable it to strengthen its role as the representative of the vaccine industry, a strategic sector for public health worldwide and Europe’s competitiveness. Read more…